IMA has submitted its response to FSA's consultation on restricting the retail distribution of UCIS and close substitutes. It, like BBA, is concerned about the breadth of the definition of "non-mainstream pooled investment". It also notes FSA is taking a broad-brush approach in seeking to ban UCIS when it already has available the right policy tools to ensure they are not mis-sold. (Source: FSA CP12/19)